SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000092
Filing Date
2021-05-04
Accepted
2021-05-04 08:00:25
Documents
5
Period of Report
2021-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesnformlisalamondandsyneos.htm 8-K 27714
2 EX-99.1 ex991_sesencommercialupd.htm EX-99.1 11395
3 GRAPHIC ex991_sesencommercialupd001.jpg GRAPHIC 270135
4 GRAPHIC ex991_sesencommercialupd002.jpg GRAPHIC 304651
5 GRAPHIC ex991_sesencommercialupd003.jpg GRAPHIC 241050
  Complete submission text file 0001485003-21-000092.txt   1164367
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 21886052
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences